The Association of Black Cardiologists (ABC) is an organization founded to bring special attention to the adverse impact of cardiovascular disease on African Americans.
The prevalence of aortic stenosis (AS) is increasing as the population ages, particularly among adults over 65 years old [1]. Despite advances in the treatment of severe AS, including transcatheter aortic valve replacement (TAVR), disparities in diagnosis, referral, and treatment persist across sex, racial, and socioeconomic groups. This review summarizes the current evidence regarding disparities in valvular heart disease (VHD) diagnosis and AS treatment, highlights barriers that contribute to inequitable access to valve replacement therapies and examines the potential of system-level interventions to improve equity in care delivery. Persistent disparities in AS care have been documented across multiple stages of the care pathway, including disease recognition, specialist referral, and receipt of aortic valve replacement (AVR). We present findings from a pragmatic randomized quality improvement intervention evaluating electronic provider notifications (EPNs) designed to improve recognition and treatment of severe AS. In a cluster-randomized trial, EPNs significantly increased rates of AVR, improved survival among symptomatic patients, and eliminated observed sex-based disparities within this study [2]. Despite the availability of effective therapies for severe AS, including TAVR, inequities in diagnosis and treatment remain substantial. Findings from the EPN trial suggest that system-level interventions integrated into routine clinical workflows may represent scalable strategies for improving both quality and equity in the delivery of life-saving therapies for severe AS [2].
Purpose ABCA4 (associated with Stargardt disease) is the gene most commonly implicated in monogenic inherited retinal disease.Fullfield ERG findings are of relevance to visual prognosis but can be difficult to predict from genotype due to the existence of a very large number of allelic variants.This study examined data from a large genetically confirmed cohort of patients with ABCA4-retinopathy, with the following aims: (1) to report prevalence of different ERG groups in a large cohort; (2) to develop and evaluate a machinelearning model to classify ERGs; and (3) to develop objective ERGbased severity scores for the more frequent ABCA4 variants.Methods ISCEV-standard full-field ERGs were recorded in 597 individuals with ABCA4-retinopathy and were classified into three functional phenotypes by expert analysis: isolated macular dysfunction (group 1; normal ERGs), macular dysfunction with additional generalised cone system dysfunction (group 2), or macular dysfunction with generalised cone and rod system dysfunction (group 3).Algorithms were developed for automatic selection of appropriate ERG traces and for automated identification and measurement of ERG parameters.A machine-learning pipeline was developed to predict ERG phenotypic group, and performance was evaluated by comparison with expert classification.Elastic-net regression was used to quantify severity of specific ABCA4 variants based on the effect on retinal function.Results By expert classification, 57.6% of the cohort were in group 1, 7.4% in group 2, and 35.0% in group 3. Machine learning classification had an overall accuracy of 91.8% (SE 0.169), with 96.7%, 39.3% and 93.8% accuracy for groups 1, 2, and 3, respectively.If the cohort was re-classified into restricted (group 1) and generalised disease (groups 2 and 3 combined) phenotypes, the average hold-out group accuracy was 93.6% (SE 0.142).The regression model assigned ERG-based severity coefficients to the 42 most frequent variants in the cohort, where lower coefficients were associated with more severe disease.Known mild variants showed high coefficients, and known null variants exhibited low coefficients.Both dark-adapted and lightadapted ERG parameters predicted similar levels of severity (average r = 0.82).Conclusion This study quantifies, by expert and automated methods, the prevalence of ERG-phenotype groups in a uniquely large singlecentre cohort of ABCA4-retinopathy and provides proof of principle for applicability of machine learning to such ERG datasets.Novel regression-based analyses of ABCA4 variant severity appeared to be accurate for those variants whose severity is already known and may provide an objective classification for variants whose functional effect is not yet defined.Such scores could predict predisposition to severe disease, potentially identifying those most likely to benefit from early therapeutic intervention.
Following decades of decline, maternal mortality began to rise in the United States around 1990—a significant departure from the world’s other affluent countries. By 2018, the same could be seen with the maternal mortality rate in the United States at 17.4 maternal deaths per 100 000 live births. When factoring in race/ethnicity, this number was more than double among non-Hispanic Black women who experienced 37.1 maternal deaths per 100 000 live births. More than half of these deaths and near deaths were from preventable causes, with cardiovascular disease being the leading one. In an effort to amplify the magnitude of this epidemic in the United States that disproportionately plagues Black women, on June 13, 2020, the Association of Black Cardiologists hosted the Black Maternal Heart Health Roundtable—a collaborative task force to tackle the maternal health crisis in the Black community. The roundtable brought together diverse stakeholders and champions of maternal health equity to discuss how innovative ideas, solutions and opportunities could be implemented, while exploring additional ways attendees could address maternal health concerns within the health care system. The discussions were intended to lead the charge in reducing maternal morbidity and mortality through advocacy, education, research, and collaborative efforts. The goal of this roundtable was to identify current barriers at the community, patient, and clinician level and expand on the efforts required to coordinate an effective approach to reducing these statistics in the highest risk populations. Collectively, preventable maternal mortality can result from or reflect violations of a variety of human rights—the right to life, the right to freedom from discrimination, and the right to the highest attainable standard of health. This is the first comprehensive statement on this important topic. This position paper will generate further research in disparities of care and promote the interest of others to pursue strategies to mitigate maternal mortality.